- Active Ingredients
Product Documentation
-
View RMM (RMM - Rivaroxaban Patient Alert Card)
Last updated on this site: 17 May 2024
Updated RMM for strengths: 2.5mg, 10mg, 15mg & 20mg.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintRivaroxaban Accord 20 mg Film-coated Tablets
- PL Number:
- PLGB 20075/1445
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Summary of Product Characteristics (SmPC - Rivaroxaban Accord 20 mg film-coated tablets)
Last updated on this site: 25 Feb 2025
Renewal approval
View Patient Information Leaflet (PIL - Rivaroxaban Accord 15mg, 20 mg film-coated tablets)Last updated on this site: 26 Aug 2025
1. To register the addition of Accord Healthcare Limited, Edgefield Avenue, Newcastle Upon Tyne, NE3 3NB, United Kingdom as the manufacturer responsible for quality control testing of the finished product.
2. To register the addition of Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow Middlesex, HA1 4HF, United Kingdom as the manufacturer responsible for batch release of the finished product. Consequently, the PIL is updated.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.